drugset

drugset / Trial / NCT04951141

Clinical Study of Intratumoral Injection of CAR-T Cells in the Treatment of Advanced Liver Tumors

NCT04951141 ↗

Phase 0 Unknown 10 enrolled Beijing Immunochina Medical Science & Technology Co., Ltd.

NaSingle-groupOpen-labelTreatment

Summary

Objective to study the safety and preliminary efficacy of intratumoral injection of CAR-T cells in the treatment of advanced liver tumors.

Timeline

Start: 2019-01-01
Primary completion: 2023-09-30
Completion: 2023-12-21

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	anti-GPC3 CAR-T cells	Cell therapy	—	Other

Indications